This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / LifeMD Securities Class Action Filed
Business class action

LifeMD Securities Class Action Filed

Analysis based on 10 articles · First reported Aug 31, 2025 · Last updated Oct 09, 2025

Sentiment
-20
Attention
2
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is impacted by the potential financial liability for LifeMD due to the class action lawsuit, which could lead to a decrease in its stock price. Investors who purchased LifeMD securities during the Class Period may be entitled to compensation, affecting their investment returns.

Pharmaceuticals Legal Services
Event Summary

Rosen Law Firm has filed a securities class action lawsuit against LifeMD, alleging that the company made materially false and misleading statements to investors between May 7, 2025, and August 5, 2025. The lawsuit claims that LifeMD overstated its competitive position and was reckless in raising its 2025 guidance without properly accounting for rising customer acquisition costs in its RexMD segment and for obesity drugs like Semaglutide and Tirzepatide. Investors who purchased LifeMD securities during this period are encouraged to join the class action, with a lead plaintiff deadline of October 27, 2025.

Entities Involved
stock
LifeMD
LifeMD is the defendant in a securities class action lawsuit, accused of making materially false and misleading statements regarding its competitive position and 2025 guidance, which could lead to financial damages for the company.
Importance 100.0 Sentiment -30.0
priv
RexMD
RexMD is a segment of LifeMD, and its rising customer acquisition costs are cited as a factor in LifeMD's allegedly misleading 2025 guidance.
Importance 40.0 Sentiment -10.0
priv
Rosen Law Firm
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.